stoxline Quote Chart Rank Option Currency Glossary
Yield10 Bioscience, Inc. (YTEN)
1.79  0.12 (7.19%)    07-19 11:23
Open: 1.82
High: 2.2
Volume: 3,926
Pre. Close: 1.67
Low: 1.66
Market Cap: 1(M)
Technical analysis
2024-07-19 2:24:56 PM
Short term     
Mid term     
Targets 6-month :  2.72 1-year :  3.17
Resists First :  2.32 Second :  2.72
Pivot price 1.12
Supports First :  1.38 Second :  0.8
MAs MA(5) :  1.42 MA(20) :  1.15
MA(100) :  4.4 MA(250) :  8.21
MACD MACD :  -0.2 Signal :  -0.4
%K %D K(14,3) :  72 D(3) :  50
RSI RSI(14): 56.8
52-week High :  54.47 Low :  0.8
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ YTEN ] has closed below upper band by 6.6%. Bollinger Bands are 48.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 29 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.33 - 2.34 2.34 - 2.35
Low: 1.63 - 1.64 1.64 - 1.65
Close: 2.07 - 2.08 2.08 - 2.09
Company Description

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.

Headline News

Wed, 17 Jul 2024
Yield10 Bioscience: Commercial License to Omega-3 Assets - EFECOMUNICA

Wed, 17 Jul 2024
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets - StockTitan

Mon, 15 Jul 2024
Yield10 Bioscience (YTEN) Price Target Increased by 23.53% to 3.57 - MSN

Thu, 23 May 2024
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label - Yahoo Finance

Wed, 15 May 2024
Yield10 Bioscience to be delisted from Nasdaq -

Wed, 15 May 2024
Yield10 Bioscience Announces Delisting from Nasdaq - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Basic Materials
Agricultural Inputs
Shares Out 1 (M)
Shares Float 1 (M)
Held by Insiders 12.3 (%)
Held by Institutions 11.5 (%)
Shares Short 3 (K)
Shares Short P.Month 39 (K)
Stock Financials
EPS -30.3
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -5.16
Profit Margin 0 %
Operating Margin -813.4 %
Return on Assets (ttm) -170.5 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 400 %
Gross Profit (p.s.) 0
Sales Per Share 0.46
EBITDA (p.s.) -19.88
Qtrly Earnings Growth 0 %
Operating Cash Flow -8 (M)
Levered Free Cash Flow -3 (M)
Stock Valuations
PE Ratio -0.06
PEG Ratio 0
Price to Book value -0.35
Price to Sales 3.83
Price to Cash Flow -0.14
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android